Overview
Panagiotis Baliakas practices practicing medicine in Uppsala, Sweden.
Mr. Baliakas is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Leukemia, Small Lymphocytic Lymphoma (SLL), and Bone Marrow Transplant.
He is actively involved in clinical research, co-authoring 90 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Panagiotis Baliakas
Is Panagiotis Baliakas a top-rated expert for Chronic Lymphocytic Leukemia (CLL)?
MediFind is an objective health platform that identifies experts based on real-world data. Panagiotis Baliakas is classified as an Elite expert for Chronic Lymphocytic Leukemia (CLL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Panagiotis Baliakas participate in research or clinical trials?
Yes. Panagiotis Baliakas has published 90 articles and abstracts on conditions like Chronic Lymphocytic Leukemia (CLL). You can view a list of Panagiotis Baliakas's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chronic B-Cell Leukemia (CBCL)Mr. Baliakas isElite. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Distinguished
- LeukemiaMr. Baliakas isDistinguished. Learn about Leukemia.
- RUNX1 Familial Platelet DisorderMr. Baliakas isDistinguished. Learn about RUNX1 Familial Platelet Disorder.
- Small Lymphocytic Lymphoma (SLL)Mr. Baliakas isDistinguished. Learn about Small Lymphocytic Lymphoma (SLL).
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Mr. Baliakas isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Splenic NeoplasmMr. Baliakas isAdvanced. Learn about Splenic Neoplasm.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Mr. Baliakas isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult Immune ThrombocytopeniaMr. Baliakas isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisMr. Baliakas isExperienced. Learn about Agranulocytosis.
- B-Cell LymphomaMr. Baliakas isExperienced. Learn about B-Cell Lymphoma.
- Blood ClotsMr. Baliakas isExperienced. Learn about Blood Clots.
- Bone Marrow TransplantMr. Baliakas isExperienced. Learn about Bone Marrow Transplant.
- Chronic T-Cell Leukemia (CTCL)Mr. Baliakas isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).
- Dyskeratosis CongenitaMr. Baliakas isExperienced. Learn about Dyskeratosis Congenita.
- Hodgkin LymphomaMr. Baliakas isExperienced. Learn about Hodgkin Lymphoma.
- Immune Thrombocytopenic Purpura (ITP)Mr. Baliakas isExperienced. Learn about Immune Thrombocytopenic Purpura (ITP).
- Marginal Zone Lymphoma (MZL)Mr. Baliakas isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- Myelodysplastic Syndrome (MDS)Mr. Baliakas isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Non-Hodgkin LymphomaMr. Baliakas isExperienced. Learn about Non-Hodgkin Lymphoma.
- Prolymphocytic LeukemiaMr. Baliakas isExperienced. Learn about Prolymphocytic Leukemia.
- PurpuraMr. Baliakas isExperienced. Learn about Purpura.